Pharmacogenomic–pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer Hiroshi IshiguroShinji OhnoMasakazu Toi Original Article Open access 07 February 2019 Pages: 535 - 543
Relationships among personality, coping, and concurrent health-related quality of life in women with breast cancer Hui-Ling LaiChun-I. ChenChiung-Yu Huang Original Article 12 February 2019 Pages: 544 - 551
The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan Wakana MurakamiMitsuhiro TozakiTakehiko Gokan Original Article Open access 28 February 2019 Pages: 552 - 561
Impact of germinal center-associated nuclear protein polymorphisms on breast cancer risk and prognosis in a Japanese population Haruru KotaniHidemi ItoKeitaro Matsuo Original Article 27 February 2019 Pages: 562 - 572
Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer Kayo FukuiNorio MasumotoMorihito Okada Original Article 13 March 2019 Pages: 573 - 580
Breast cancer cell motility is promoted by 14-3-3γ Emiko HiraokaTakahiro MimaeMorihito Okada Original Article 04 March 2019 Pages: 581 - 593
Correction to: Breast cancer cell motility is promoted by 14-3-3γ Emiko HiraokaTakahiro MimaeMorihito Okada Correction 29 March 2019 Pages: 594 - 594
Lateral thoracoaxillar dermal-fat flap for breast conserving surgery: the changes of the indication and long-term results Hiroshi NakagomiMasayuki InoueKoichi Kobayashi Original Article 07 March 2019 Pages: 595 - 601
C677T and A1298C methylenetetrahydrofolate reductase polymorphisms and breast cancer susceptibility among Latinos: a meta-analysis Perla Meneses-SanchezSamantha C. Garcia-HernandezM. Elba Gonzalez-Mejia Original Article 15 March 2019 Pages: 602 - 611
Sentinel node mapping and ductal carcinoma in situ Samara E. PollockJondavid PollockDavid Ghaphery Original Article 22 March 2019 Pages: 612 - 617
Oncologic outcomes and radiation safety of nipple-sparing mastectomy with intraoperative radiotherapy for breast cancer Lingxiao PanChangsheng YeWenbo Zheng Original Article 19 March 2019 Pages: 618 - 627
Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer Fumi KatoKohsuke KudoHiroki Shirato Original Article 01 April 2019 Pages: 628 - 636
Neutropenia management with palbociclib in Japanese patients with advanced breast cancer Norikazu MasudaHirofumi MukaiMasakuzu Toi Original Article Open access 24 May 2019 Pages: 637 - 650
Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer Norikazu MasudaHirofumi MukaiMasakazu Toi Correction 05 June 2019 Pages: 651 - 651
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan Yukie OmoriSotaro EnatsuHiroshi Ishiguro Original Article Open access 04 April 2019 Pages: 652 - 662
PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation Xueqiang GaoXiangping LiuHaibo Wang Original Article Open access 15 April 2019 Pages: 663 - 671
Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy Anbok LeeSunmi JoYunseon Choi Original Article 29 March 2019 Pages: 672 - 680
Discrepancies of current recommendations in breast cancer follow-up: a systematic review Anastasios KyriazoglouFlora ZagouriMeletios Athanasios Dimopoulos Rapid Communication 18 March 2019 Pages: 681 - 686
